Girolamo Pelaia

Increased activation of p38 MAPK in COPD

Teresa Renda, Simonetta Baraldo, Girolamo Pelaia et al. · European Respiratory Journal · 2007 · 262 citations · Full text

Medicine, Cell Biology, Inflammation +16

The Severe Asthma Network in Italy: Findings and Perspectives

Enrico Heffler, Francesco Blasi, Manuela Latorre et al. · The Journal of Allergy and Clinical Immunology In Practice · 2018 · 179 citations · Full text

Medicine, Health Sciences, Internal Medicine +12

Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial

Tim Harrison, Pascal Chanez, Francesco Menzella et al. · The Lancet Respiratory Medicine · 2020 · 175 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +15

Shadow cost of oral corticosteroids-related adverse events: A pharmacoeconomic evaluation applied to real-life data from the Severe Asthma Network in Italy (SANI) registry

Giorgio Walter Canonica, Giorgio Lorenzo Colombo, Giacomo Matteo Bruno et al. · World Allergy Organization Journal · 2019 · 119 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacology +17

Italian real-life experience of omalizumab

M. Cazzola, Gianna Camiciottoli, Marco Bonavia et al. · Respiratory Medicine · 2010 · 108 citations

Pharmacy, Pharmacotherapy, Everyday Life Studies +1